Cowen Inc’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$2.26M Sell
45,000
-8,965
-17% -$436K 0.16% 102
2019
Q1
$2.81M Buy
53,965
+18,965
+54% +$874K 0.3% 64
2018
Q4
$1.71M Buy
35,000
+18,000
+106% +$991K 0.19% 105
2018
Q3
$1.11M Sell
17,000
-3,000
-15% -$176K 0.1% 135
2018
Q2
$993 Buy
+20,000
New +$968K 0.04% 214

Other funds holding MYOK

Cowen Inc's MYOK Position: Q2 2019 in Review

Cowen Inc reduced its MyoKardia, Inc. Common Stock (MYOK) stake by 17% in Q2 2019, selling an estimated $436K and leaving 45,000 shares worth $2.26M. The position accounts for 0.16% of the portfolio, ranked #102.

Cowen Inc first reported a position in MYOK in Q2 2018 and has held it in 5 quarters since. The position peaked at $2.81M in Q1 2019. 155 funds tracked by Wall St. Rank hold MYOK as of Q2 2019.

  • Cowen Inc held 45,000 shares of MyoKardia, Inc. Common Stock worth $2.26M as of Q2 2019.
  • Cowen Inc sold 8,965 MyoKardia, Inc. Common Stock shares in Q2 2019, an estimated $436K.
  • MyoKardia, Inc. Common Stock made up 0.16% of Cowen Inc's portfolio in Q2 2019, its #102 holding.
  • Cowen Inc first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's MyoKardia, Inc. Common Stock position peaked at $2.81M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.